Your payment is in progress...

Osteoporosis Drugs Market – By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, And Others), By Regions (North America, Europe, Asia Pacific, And Rest Of The World) – Global Forecast Up To 2025

Published on: Sep 2019 | From USD $2750 | Published By: INFOHOLICRESEARCH | Number Of Pages: 70

Global Osteoporosis Drugs Market: Forecast up to 2025
[70 pages report] This market research report includes a detailed segmentation of the global osteoporosis drugs market by drug class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), and by Regions (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Global Osteoporosis Drugs Market Research:
Infoholics market research report predicts that the global osteoporosis drugs market will grow at a CAGR of 4.3% during the forecast period. Osteoporosis or porous bone or thinning bones is a disease associated by low bone mass and bone tissue structural deterioration, resulting in bone fragility and enhanced risk of fractures of the spine, hip and wrist. It mainly effects elderly population, especially women who have already experienced menopause.
Upsurge in the prevalence of osteoporosis in postmenopausal women, increase in aging population, and increasing awareness among public about osteoporosis care are some of the important factors driving the market growth. Aging population is major risk factor for the development of osteoporosis, nearly 9.9 million people live with osteoporosis in US and an additional 43.1 million have low bone mineral density (BMD). However, expiration of the patents and side-effects associated with the drugs such as nausea, difficulty in swallowing, heartburn, and gastric ulcer are some of the factors that may prove detrimental for the market. Growing investment in R&D for drug discovery and development and rising healthcare expenditure is anticipated to enhance the revenue of osteoporosis drugs market in next five years.
International Osteoporosis Foundation estimates that around 200 million individuals globally suffer from osteoporosis disease. Currently, it is estimated that over 200 million people worldwide suffer from this disease. Nearly 30% of all postmenopausal women have osteoporosis in the US and in Europe. According to National Institute of Health, about 53 million individuals in US either suffer from osteoporosis or at an increased risk due to low bone mass. The increasing patient base for osteoporosis diseases ensures constant growth of the market during the forecast period 2019 to 2025.

The industry generates majority of the revenue by the key players operating in this market few of them include Amgen, Inc., Eli Lilly & Company Ltd., Novartis AG, Pfizer Inc., Radius Health, Inc., and Merck & Co.
According to Infoholic Research analysis, North America accounted for the largest share of the global osteoporosis drugs market in 2018 and will retain a high position during the forecast period. North America is followed by Europe with a share of more than 20% of the global market in 2018.
By Drug Class:
Bisphosphonates
Parathyroid Hormone Therapy
Selective Estrogen Receptor Modulator
RANK Ligand Inhibitors
Biosimilars
Others
In 2018, the bisphosphonates segment accounted for the largest share and is expected to grow at a low-single-digit CAGR by 2025. The biosimilars is expected to grow at a high CAGR during the forecast period 20192025. The patent of bestselling osteoporosis drugs is going to expire, which is paving way for the emergence of biosimilars. For instance, the patent of Amgens Prolia (Denosumab) will expire in the US in 2025 and in Europe in 2022. Currently there are five drug companies conducting ongoing clinical development of Denosumab biosimilar. Intas pharmaceuticals and AryoGen Pharmed are in advanced phase III clinical trial, whereas other two companies are in preclinical and pipeline phase.
By Regions:
North America
Europe
Asia Pacific
Rest of the World
Based on geography, North America dominated the market in 2018 with a market share of over 40% and is expected to maintain this position throughout the forecast period. The presence of established medical and healthcare infrastructure, increasing patient base for osteoporosis, and existence of reputed players extensively involved in the commercialization of branded therapeutics make North America a dominant shareholder in the global osteoporosis drugs market. Asia Pacific is projected to grow at high CAGR during the forecast period 20192025.
Global Osteoporosis Drugs Market Research Competitive Analysis: The market is growing at a steady rate with a CAGR of 4.3% during the forecast period 20192025. There is an increase in new approvals, collaboration, and development of new osteoporosis drugs due to the increase in its incidence worldwide. For instance, FDA approved Evenity (romosozumab) to treat osteoporosis in postmenopausal women in April 2019 to those who have failed or intolerant to other osteoporosis therapies. South Korean based Yuyu Pharmaceutical launched Bazestar for the treatment of osteoporosis in late 2018. This drug is a selective estrogen receptor modulator used for treating and preventing osteoporosis in postmenopausal women.
In addition, other leading vendors are focusing on hugely investing in R&D activities to develop new drugs to obtain a high share in the market. Sandoz announced start of clinical study for its proposed biosimilar denosumab for osteoporosis in July 2019. Iran based AryoGen Pharmed is conducting phase III trial for biosimilar Prolia and the trial is expected to be completed by the end of this year.
Key Vendors:
Amgen, Inc.
Novartis AG
Eli Lilly & Company Ltd.
Pfizer, Inc.
Radius Health, Inc.
Teva Pharmaceuticals Industries Ltd.
GlaxoSmithKline plc
Merck & Co.
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
Key Competitive Facts:
Lasofoxifene (a new selective estrogen receptor modulator [SERM] or estrogen agonist-antagonist [EAA] with partial agonist activity at both estrogen receptors ER? and ER?); abaloparatide (a parathyroid hormone [PTH]-related protein analog); balicatib (inhibitors of the resorptive enzyme cathepsin K) are some of the molecules currently undergoing clinical trial for Food and Drug Administration approval.
In March 2019, Pfenex announced an agreement with Alvogen to develop and commercialize PF708, a follow-on teriparatide product referencing Forteo to treat osteoporosis in the EU, some countries in North Africa, Middle East and other territories.
Benefits The report provides complete details about the sub-segment of the global osteoporosis drugs market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.
Key Takeaways:
Understanding the potential market opportunity with precise market size and forecast data.
Detailed market analysis focusing on the growth of osteoporosis drugs industry.
Factors influencing the growth of the osteoporosis drugs market.
In-depth competitive analysis of dominant and pure-play vendors.
Prediction analysis of the osteoporosis drugs industry in both developed and developing regions.
Key insights related to major segments of the osteoporosis drugs market.
Latest market trend analysis impacting the buying behavior of the consumers.

Key Stakeholders:

Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.1.1 Global Driver for Pharmaceutical Demand 11
1.1.2 R&D Pipeline in Pharmaceutical Industry 11
1.1.3 Top Pharma Drugs by Sales (In $Million) 12
1.2 Industry Trends 12
2 Report Outline 14
2.1 Report Scope 14
2.2 Report Summary 14
2.3 Research Methodology 15
2.4 Report Assumptions 15
3 Market Snapshot 17
3.1 Market Definition – Infoholic Research 17
3.2 Causes of Osteoporosis 17
3.3 Risk Factors for Osteoporosis 17
3.4 Symptoms of Osteoporosis 18
3.5 Segmented Addressable Market (SAM) 18
3.6 Trends of the Osteoporosis Drugs Market 18
3.7 Related Markets 20
3.7.1 Thrombosis Drugs 20
3.7.2 Immunotherapy Drugs 21
3.7.3 Oncology Drugs 22
4 Market Outlook 24
4.1 Market Segmentation 24
4.2 PEST Analysis 25
4.3 Porter 5 (Five) Forces 26
5 Market Characteristics 27
5.1 DRO –Market Dynamics 27
5.1.1 Drivers 27
5.1.1.1 Increasing geriatric population and upsurge in the incidence of osteoporosis 27
5.1.1.2 Growing awareness about osteoporotic care 28
5.1.2 Opportunities 28
5.1.2.1 Rise in healthcare expenditure in developing countries 28
5.1.2.2 Increased approval of new drugs and pipeline products 28
5.1.3 Restraints 29
5.1.3.1 Expiration of patents and emergence of generics 29
5.1.3.2 Side-effects associated with osteoporosis drugs 29
5.2 DRO – Impact Analysis 30
5.3 Key Stakeholders 31
6 Drug Class: Market Size and Analysis 32
6.1 Overview 32
6.2 Bisphosphonates 33
6.3 Parathyroid Hormone Therapy (PTH) 34
6.4 Selective Estrogen Receptor Modulator (SERM) 35
6.5 Rank Ligand Inhibitors 35
6.6 Biosimilars 36
6.7 Others 37
7 Regions: Market Size and Analysis 39
7.1 Overview 39
7.2 North America 40
7.3 Europe 41
7.4 APAC 42
7.4.1 Overview 42
7.5 Rest of the World 43
8 Competitive Landscape 45
8.1 Overview 45
9 Vendors Profile 47
9.1 Amgen, Inc. 47
9.2 Novartis AG 49
9.3 Eli Lilly & Company Ltd. 52
9.4 Pfizer Inc. 55
9.5 Radius Health, Inc. 58
10 Companies to Watch For 61
10.1 Teva Pharmaceutical Industries Ltd. 61
10.2 F. Hoffmann-La Roche Ltd. 62
10.3 GlaxoSmithKline plc 64
10.4 Novo Nordisk A/S 65
10.5 Merck & Co. 67
Annexure 70
Abbreviations 70

?

Same as Description

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

FAQs

Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research.

The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.
The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more.

These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry.

Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website). There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Any person who has the capacity to make decisions for the business must buy the reports. These reports help management in decision making process. Market research helps person to obtain market information from different sources, and in multiple formats. It aims to study supply and demand, analyze data as per geography, age factors, demography, technology, product, psychographic & gender differences, and many other parameters. Access to in-depth market trends helps person to assess the market effectiveness. Some of the multiple techniques used for market research include customer analysis, choice modeling, competition and risk analysis, product research, advertising the research, marketing mix modeling, simulated test marketing, and more.
Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors. This helps person in the decision-making process of planning and implementing strategies for their markets.

The generation of research report is concerned by most clients when purchasing it. Following general steps are taken for generating reports.
1. Choose a topic.
2. Make skeleton catalogue.
3. Fill content. As for report content, there are two main information source, Primary and Secondary data collection. Secondary data collectionrefers to information searched from the Internet or data bought from database. Primary data collection refers to information concluded from telephone interview, face-to-face interview, expert’s interview, meeting etc.
4. Audit the report
5. Publish the report.

With regard to information cost, information searching costs the least, database support the second least, and telephone interview the third least. Face-face interview cost higher, in-depth interview much higher and expert interview the highest. A research may adopt all of these approaches, or just some of them.
In general, a good-quality research report needs 1-3 months to be finished. Time and method varies according to different Publishers. Thus, it’s difficult to define an exact procedure or process of making research report. Both time and cost vary. However, specialization has become a basic industry standard. Professional and dedicated products will be more and more popular.
MarketInsightsReports has focused on various fields such as Life Science, IT, Telecommunication, Food& Beverages, Energy & Power, Automotive & Transportation, Materials& Chemicals, Financial Services and many more. These market research reports are available for all regions around the globe.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website).

There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Please Choose License Type

USD $2750
USD $3500
USD $4500
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Recognised publishing sources Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Customer Support Customer Support
    Complete pre and post sales support.
  • Safe & Secure Safe & Secure
    Complete secure payment process.